Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02938650Phase 1Completed
Phase 1, open-label, single-arm trial of Nitrosomonas eutropha in dermatitis, sponsored by University of California, Davis. Primary endpoints: Alteration in microbiome diversity and species at 1 week and Alteration in nitrolipids in the skin at 1 week. Started Oct 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02938650.